Rhode Island Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center

• Category: Corporations - Public - Licenses
• State: Multi-State
• Control #: US-EG-9161
• Format: Word; Rich Text

Description

Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center at Forth Worth dated July 1, 1996. 2 pages Rhode Island Collateral License Agreement is a legal contract signed between Gentling, Inc. and The University of North Texas Health Science Center (UNT HSC) to establish rights and responsibilities regarding intellectual property, research findings, and commercialization efforts. This agreement aims to protect both parties' interests in various scenarios, such as technology transfer, patents, trademark rights, and royalties. Keywords: Rhode Island Collateral License Agreement, Gentling, Inc., The University of North Texas Health Science Center, intellectual property, research findings, commercialization, technology transfer, patents, trademark rights, royalties. Different Types of Rhode Island Collateral License Agreement: 1. Technology Transfer Agreement: This type of agreement outlines the terms and conditions for the transfer of technology from The University of North Texas Health Science Center to Gentling, Inc. It includes details about the intellectual property rights, licensing, royalties, and commercialization strategies. 2. Patent License Agreement: In the case where UNT HSC has acquired a patent for a specific invention or technology, the Patent License Agreement defines the licensing terms and conditions, royalties, exclusivity, and rights granted to Gentling, Inc. for commercializing the patented technology in Rhode Island. 3. Trademark License Agreement: This agreement focuses on licensing the use of specific trademarks or branding associated with the products or services developed as part of the collaboration between Gentling, Inc. and UNT HSC. It outlines the terms, duration, and conditions for using the trademarks in Rhode Island. 4. Royalty Agreement: A Royalty Agreement establishes the payment terms and conditions for Gentling, Inc. to provide UNT HSC with a percentage of the revenue generated from the commercialization of products or services developed using the licensed intellectual property. It may include specific milestones, payment schedules, and reporting requirements to ensure transparency and fair compensation. Overall, Rhode Island Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center aims to facilitate the effective transfer and commercialization of intellectual property, fostering collaboration and driving innovation in Rhode Island's health science sector.

Rhode Island Collateral License Agreement is a legal contract signed between Gentling, Inc. and The University of North Texas Health Science Center (UNT HSC) to establish rights and responsibilities regarding intellectual property, research findings, and commercialization efforts. This agreement aims to protect both parties' interests in various scenarios, such as technology transfer, patents, trademark rights, and royalties. Keywords: Rhode Island Collateral License Agreement, Gentling, Inc., The University of North Texas Health Science Center, intellectual property, research findings, commercialization, technology transfer, patents, trademark rights, royalties. Different Types of Rhode Island Collateral License Agreement: 1. Technology Transfer Agreement: This type of agreement outlines the terms and conditions for the transfer of technology from The University of North Texas Health Science Center to Gentling, Inc. It includes details about the intellectual property rights, licensing, royalties, and commercialization strategies. 2. Patent License Agreement: In the case where UNT HSC has acquired a patent for a specific invention or technology, the Patent License Agreement defines the licensing terms and conditions, royalties, exclusivity, and rights granted to Gentling, Inc. for commercializing the patented technology in Rhode Island. 3. Trademark License Agreement: This agreement focuses on licensing the use of specific trademarks or branding associated with the products or services developed as part of the collaboration between Gentling, Inc. and UNT HSC. It outlines the terms, duration, and conditions for using the trademarks in Rhode Island. 4. Royalty Agreement: A Royalty Agreement establishes the payment terms and conditions for Gentling, Inc. to provide UNT HSC with a percentage of the revenue generated from the commercialization of products or services developed using the licensed intellectual property. It may include specific milestones, payment schedules, and reporting requirements to ensure transparency and fair compensation. Overall, Rhode Island Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center aims to facilitate the effective transfer and commercialization of intellectual property, fostering collaboration and driving innovation in Rhode Island's health science sector.